ArticleHaematologica2024

Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated antitumor efficacy of tafasitamab.

Alexander Biedermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.